Overview


According to FutureWise analysis the market for cardiovascular prosthetic devices in 2023 is US$ 31.89 billion, and is expected to reach US$ 62.71 billion by 2031 at a CAGR of 8.8%.

A cardiovascular prosthetic device replaces damaged heart tissue. The devices are designed in a way that mimics the functioning of normal cardiovascular organs. The use of cardiac prosthetic devices has allowed heart surgeons to improve the treatment of heart blockages. The most commonly used cardiac prosthetic devices are heart valves and pacemakers. An increase in cardiac disorder cases will drive the market for cardiac prosthetic devices. There is an ever-growing market for cardiac prosthetic devices due to the increasing prevalence of cardiac disorders. The American population suffers from heart valve disorders annually to the tune of around 5 million people. Moreover, the rising adoption rate for these devices along with the growing geriatric population as well as the unhealthy lifestyle of the current generation will drive the market. The high cost of these devices hinders the growth of the market. The report segments the cardiovascular prosthetic devices market by type and geography. According to type, the market is segmented into cardiac prosthetic devices and vascular prosthetic devices. Furthermore, cardiac prosthetic devices can be classified as prosthetic heart valves, annuloplasty rings, pacemaker leads, defibrillator leads, tissue patches, ventricular assist devices, and artificial hearts.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cardiovascular Prosthetic Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cardiovascular Prosthetic Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott Laboratories
  • Edwards Lifesciences Corp.
  • W. L. Gore and Associates, Inc.
  • Medtroic plc.
  • Sorin Group
  • St. Jude Medical, Inc.
  • B. Braun Melsungen AG
  • Meril Life Sciences Pvt. Ltd.
  • SYMETIS SA
  • Lifetech Scientific (Shenzhen) Co., Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Cardiac Prosthetic Devices
    • Prosthetic Heart Valves
      • Mechanical Heart Valve
      • Tissue Heart Valve
      • Transcatheter Heart Valve
    • Annuloplasty Rings
      • Flexible Annuloplasty Ring
      • Semi-Rigid Annuloplasty Ring
      • 3D Annuloplasty Ring
    • Pacemaker Leads
    • Defibrillator Leads
    • Tissue Patches
    • Ventricular Assist Devices
      • Right Ventricular Assist Devices (RVAD)
      • Left Ventricular Assist Devices (LVAD)
      • Bipolar Ventricular Assist Devices (BVAD)
    • Artificial Hearts
  • Vascular Prosthetic Devices
    • Synthetic Grafts
      • PTFE
      • Teflon
      • Dacron
    • Pericardial Tissue Patches
    • Synthetic Patches
    • Vascular Stents
    • Endovascular Device

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cardiovascular Prosthetic Devices Market By Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cardiovascular Prosthetic Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cardiovascular Prosthetic Devices Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cardiovascular Prosthetic Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cardiovascular Prosthetic Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiac Prosthetic Devices
         1.1. Prosthetic Heart Valves
          1.1.1. Mechanical Heart Valve
          1.1.2. Tissue Heart Valve
          1.1.3. Transcatheter Heart Valve
         1.2. Annuloplasty Rings
          1.2.1. Flexible Annuloplasty Ring
          1.2.2. Semi-Rigid Annuloplasty Ring
          1.2.3. 3D Annuloplasty Ring
         1.3. Pacemaker Leads
         1.4. Defibrillator Leads
         1.5. Tissue Patches
         1.6. Ventricular Assist Devices
          1.6.1. Right Ventricular Assist Devices (RVAD)
          1.6.2. Left Ventricular Assist Devices (LVAD)
          1.6.3. Bipolar Ventricular Assist Devices (BVAD)
         1.7. Artificial Hearts
        2. Vascular Prosthetic Devices
         2.1. Synthetic Grafts
          2.1.1. PTFE
          2.1.2. Teflon
          2.1.3. Dacron
         2.2. Pericardial Tissue Patches
         2.3. Synthetic Patches
         2.4. Vascular Stents
         2.5. Endovascular Device

  • 8.   North America Cardiovascular Prosthetic Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 9.   Latin America Cardiovascular Prosthetic Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 10.   Europe Cardiovascular Prosthetic Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.7. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 11.   Asia Pacific Cardiovascular Prosthetic Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 12.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 13.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •         1. Abbott Laboratories
                  1.1. Company Overview
                  1.2. Product Portfolio
                  1.3. SWOT Analysis
                  1.4. Financial Overview
                  1.5. Strategic Overview
              2. Edwards Lifesciences Corp.
                  2.1. Company Overview
                  2.2. Product Portfolio
                  2.3. SWOT Analysis
                  2.4. Financial Overview
                  2.5. Strategic Overview
              3. W. L. Gore & Associates, Inc.
                  3.1. Company Overview
                  3.2. Product Portfolio
                  3.3. SWOT Analysis
                  3.4. Financial Overview
                  3.5. Strategic Overview
              4. Medtroic plc.
                  4.1. Company Overview
                  4.2. Product Portfolio
                  4.3. SWOT Analysis
                  4.4. Financial Overview
                  4.5. Strategic Overview
              5. Sorin Group
                  5.1. Company Overview
                  5.2. Product Portfolio
                  5.3. SWOT Analysis
                  5.4. Financial Overview
                  5.5. Strategic Overview
              6. St. Jude Medical, Inc.
                  6.1. Company Overview
                  6.2. Product Portfolio
                  6.3. SWOT Analysis
                  6.4. Financial Overview
                  6.5. Strategic Overview
              7. B. Braun Melsungen AG
                  7.1. Company Overview
                  7.2. Product Portfolio
                  7.3. SWOT Analysis
                  7.4. Financial Overview
                  7.5. Strategic Overview
              8. Meril Life Sciences Pvt. Ltd.
                  8.1. Company Overview
                  8.2. Product Portfolio
                  8.3. SWOT Analysis
                  8.4. Financial Overview
                  8.5. Strategic Overview
              9. SYMETIS SA
                  9.1. Company Overview
                  9.2. Product Portfolio
                  9.3. SWOT Analysis
                  9.4. Financial Overview
                  9.5. Strategic Overview
              10. Lifetech Scientific (Shenzhen) Co., Ltd.
                  10.1. Company Overview
                  10.2. Product Portfolio
                  10.3. SWOT Analysis
                  10.4. Financial Overview
                  10.5. Strategic Overview

  • 15.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 16.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients